Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMINOSALICYLATE vs AMLODIPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMINOSALICYLATE vs AMLODIPINE: Safety Overview

Metric AMINOSALICYLATE AMLODIPINE
Total FAERS Reports 272 64,924
Deaths Reported 203 10,161
Death Rate 74.6% 15.7%
Hospitalizations 179 26,787
Average Patient Age 43.7 yrs 62.8 yrs
% Female Patients 82.2% 57.0%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 12, 2011
Manufacturer N/A Teva Pharmaceuticals USA, Inc.
Route N/A ORAL
Marketing Status Discontinued Prescription